Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 284

1.

Evaluation of a Population Based Approach to Familial Colorectal Cancer.

Parfrey PS, Dicks E, Parfrey O, McNicholas PJ, Noseworthy H, Woods MO, Negriin C, Green J.

Clin Genet. 2016 Oct 3. doi: 10.1111/cge.12877. [Epub ahead of print]

PMID:
27696385
2.

The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial.

Abdalla S, Montez-Rath ME, Parfrey PS, Chertow GM.

Contemp Clin Trials. 2016 May;48:119-24. doi: 10.1016/j.cct.2016.04.001.

PMID:
27080930
3.

Analyzing Health-Related Quality of Life in the EVOLVE Trial: The Joint Impact of Treatment and Clinical Events.

Briggs AH, Parfrey PS, Khan N, Tseng S, Dehmel B, Kubo Y, Chertow GM, Belozeroff V.

Med Decis Making. 2016 Nov;36(8):965-72. doi: 10.1177/0272989X16638312.

PMID:
26987347
4.

Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.

Hodgkinson KA, Howes AJ, Boland P, Shen XS, Stuckless S, Young TL, Curtis F, Collier A, Parfrey PS, Connors SP.

Circ Arrhythm Electrophysiol. 2016 Mar;9(3). pii: e003589. doi: 10.1161/CIRCEP.115.003589.

PMID:
26966288
5.

Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients.

Savio AJ, Daftary D, Dicks E, Buchanan DD, Parfrey PS, Young JP, Weisenberger D, Green RC, Gallinger S, McLaughlin JR, Knight JA, Bapat B.

BMC Cancer. 2016 Feb 17;16:113. doi: 10.1186/s12885-016-2149-9.

6.

Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial.

Belozeroff V, Chertow GM, Graham CN, Dehmel B, Parfrey PS, Briggs AH.

Value Health. 2015 Dec;18(8):1079-87. doi: 10.1016/j.jval.2015.08.007.

7.

Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis.

Parfrey PS, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Chertow GM.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):539-46. doi: 10.2215/CJN.06370615. Review.

PMID:
26614406
8.

Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

Pun PH, Abdalla S, Block GA, Chertow GM, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Goodman WG, Herzog CA, London GM, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Middleton JP.

Hemodial Int. 2016 Jul;20(3):421-31. doi: 10.1111/hdi.12382.

PMID:
26564024
9.

Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.

Lewis EF, Claggett B, Parfrey PS, Burdmann EA, McMurray JJ, Solomon SD, Levey AS, Ivanovich P, Eckardt KU, Kewalramani R, Toto R, Pfeffer MA.

Am Heart J. 2015 Aug;170(2):322-9. doi: 10.1016/j.ahj.2015.05.008.

PMID:
26299230
10.

Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.

Kubo Y, Sterling LR, Parfrey PS, Gill K, Mahaffey KW, Gioni I, Trotman ML, Dehmel B, Chertow GM.

Pharm Stat. 2015 Jul-Aug;14(4):368. doi: 10.1002/pst.1694. No abstract available.

PMID:
26096896
11.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*..

Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876.

12.

The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial.

Chang TI, Abdalla S, London GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Dehmel B, Goodman WG, Chertow GM.

J Hum Hypertens. 2016 Mar;30(3):204-9. doi: 10.1038/jhh.2015.56.

PMID:
26040438
13.

Psychometric properties of the Patient's Perception of Life on Hemodialysis Scale.

Twomey JC, Barrett BJ, Way CY, Churchill DN, Parfrey PS.

J Nurs Meas. 2015;23(1):72-81.

PMID:
25985496
14.

The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Floege J, Kubo Y, Floege A, Chertow GM, Parfrey PS.

Clin J Am Soc Nephrol. 2015 May 7;10(5):800-7. doi: 10.2215/CJN.10221014.

15.

Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.

Kubo Y, Sterling LR, Parfrey PS, Gill K, Mahaffey KW, Gioni I, Trotman ML, Dehmel B, Chertow GM.

Pharm Stat. 2015 May-Jun;14(3):242-51. doi: 10.1002/pst.1680. Erratum in: Pharm Stat. 2015 Jul-Aug;14(4):368.

PMID:
25851955
16.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators..

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814.

17.

Clinical genetic research 1: Bias.

Stuckless S, Parfrey PS.

Methods Mol Biol. 2015;1281:333-48. doi: 10.1007/978-1-4939-2428-8_20.

PMID:
25694320
18.

Randomized controlled trials: planning, monitoring, and execution.

Hatfield E, Dicks E, Parfrey PS.

Methods Mol Biol. 2015;1281:273-86. doi: 10.1007/978-1-4939-2428-8_16.

PMID:
25694316
19.

Randomized controlled trials 7: Analysis and interpretation of quality-of-life scores.

Foley RN, Parfrey PS.

Methods Mol Biol. 2015;1281:261-72. doi: 10.1007/978-1-4939-2428-8_15.

PMID:
25694315
20.

Randomized controlled trials 6: On contamination and estimating the actual treatment effect.

Parfrey PS.

Methods Mol Biol. 2015;1281:249-59. doi: 10.1007/978-1-4939-2428-8_14.

PMID:
25694314
Items per page

Supplemental Content

Loading ...
Support Center